bid for arana 1.40...herald, page-7

Abbott could be a chance but this product is only about to start phase 3 trials so its still 12 months down the track before the product could be sold to the punter. I think Glaxo would be real interested as there would be no more royalty payments and you would also get all the pet stuff which could be re sold and a a product about to start phase 3 trials.